Anito, Antonio T.
HRN: 00-31-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2022
CEFTAZIDIME 1GM (VIAL)
08/10/2022
08/16/2022
IVT
1gm
Q8
Copd In Ae, Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes